piracetam has been researched along with Chronic Insomnia in 6 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Efficacy results are reported for all seizure types [intention-to-treat (ITT) population, N = 217] and subpopulations with tonic-clonic (n = 152), myoclonic (n = 121), and/or absence (n = 70) seizures at baseline." | 6.77 | Adjunctive levetiracetam in children, adolescents, and adults with primary generalized seizures: open-label, noncomparative, multicenter, long-term follow-up study. ( Delanty, N; Jones, J; Tonner, F, 2012) |
| "Levetiracetam was generally well tolerated, and adverse events were relatively uncommon in patients who responded to treatment." | 5.33 | Levetiracetam as adjunctive antiepileptic therapy for patients with tuberous sclerosis complex: a retrospective open-label trial. ( Chuck, G; Collins, JJ; Franz, DN; Leonard, JM; Tudor, C, 2006) |
| "Efficacy results are reported for all seizure types [intention-to-treat (ITT) population, N = 217] and subpopulations with tonic-clonic (n = 152), myoclonic (n = 121), and/or absence (n = 70) seizures at baseline." | 2.77 | Adjunctive levetiracetam in children, adolescents, and adults with primary generalized seizures: open-label, noncomparative, multicenter, long-term follow-up study. ( Delanty, N; Jones, J; Tonner, F, 2012) |
| "Levetiracetam was generally well tolerated, and adverse events were relatively uncommon in patients who responded to treatment." | 1.33 | Levetiracetam as adjunctive antiepileptic therapy for patients with tuberous sclerosis complex: a retrospective open-label trial. ( Chuck, G; Collins, JJ; Franz, DN; Leonard, JM; Tudor, C, 2006) |
| "Finally it is suggested that insomnia and the loss of REM sleep may also contribute to the onset of the condition." | 1.27 | [Changes in the circadian rhythm of urinary cyclic adenosine monophosphate during the alcoholic withdrawal syndrome and related neurobiological correlations]. ( Cedaro, P; Di Piazza, V; Geatti, O; Lattuada, L; Marchetti, E; Nardoni, A, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zakharov, VV | 1 |
| Delanty, N | 1 |
| Jones, J | 1 |
| Tonner, F | 1 |
| Zhou, JY | 1 |
| Tang, XD | 1 |
| Huang, LL | 1 |
| Zhong, ZQ | 1 |
| Lei, F | 1 |
| Zhou, D | 1 |
| Collins, JJ | 1 |
| Tudor, C | 1 |
| Leonard, JM | 1 |
| Chuck, G | 1 |
| Franz, DN | 1 |
| Siniscalchi, A | 1 |
| Gallelli, L | 1 |
| De Fazio, S | 1 |
| De Sarro, G | 1 |
| Nardoni, A | 1 |
| Di Piazza, V | 1 |
| Marchetti, E | 1 |
| Geatti, O | 1 |
| Cedaro, P | 1 |
| Lattuada, L | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| An Open-label, Multicenter, Follow-up Study to Evaluate the Safety and Efficacy of Levetiracetam (LEV) (Oral Tablets of 166, 250 or 500 mg b.i.d.), at Individualized Doses up to a Maximum of 4000 mg/Day (or 80 mg/kg/Day for Children and Adolescents Less T[NCT00150748] | Phase 3 | 217 participants (Actual) | Interventional | 2001-11-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for piracetam and Chronic Insomnia
| Article | Year |
|---|---|
Adjunctive levetiracetam in children, adolescents, and adults with primary generalized seizures: open-label, noncomparative, multicenter, long-term follow-up study.
Topics: Adolescent; Adult; Anticonvulsants; Anxiety; Child; Child, Preschool; Depression; Dose-Response Rela | 2012 |
5 other studies available for piracetam and Chronic Insomnia
| Article | Year |
|---|---|
[Vinpotropil in the treatment of dyscirculatory encephalopathy with cognitive impairment without dementia].
Topics: Adult; Aged; Cognition Disorders; Dementia, Vascular; Dizziness; Drug Administration Schedule; Drug | 2010 |
The acute effects of levetiracetam on nocturnal sleep and daytime sleepiness in patients with partial epilepsy.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Disorders of Excessive Somnolence; Electroencephalography; | 2012 |
Levetiracetam as adjunctive antiepileptic therapy for patients with tuberous sclerosis complex: a retrospective open-label trial.
Topics: Adolescent; Adult; Anorexia; Anticonvulsants; Behavioral Symptoms; Child; Child, Preschool; Dose-Res | 2006 |
Psychic disturbances associated with sodium valproate plus levetiracetam.
Topics: Anticonvulsants; Anxiety; Drug Therapy, Combination; Epilepsies, Partial; Female; Humans; Levetirace | 2007 |
[Changes in the circadian rhythm of urinary cyclic adenosine monophosphate during the alcoholic withdrawal syndrome and related neurobiological correlations].
Topics: Adult; Alcoholism; Circadian Rhythm; Clonidine; Cyclic AMP; Female; Humans; Piracetam; Sleep Initiat | 1985 |